Mandate

Vinge advises Actic Group AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Actic Group AB (publ) (”Actic”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on 28 March 2017 and the first day of trading on Nasdaq Stockholm was 7 April 2017.

The offer price was SEK 50.50 per share, corresponding to a market value for Actic of approximately SEK 800 million. The offer related to 8 613 860 shares, of which 5 346 534 were newly issued shares and 3 267 326 were existing shares which were offered by the selling shareholder Actic International S.à r.l., which is owned by IK 2007 Fund. The total value of the offer amounted to approximately SEK 500 million on the assumption that the oversubscription option is exercised in full.

Actic is a North European operator of health care facilities focusing on Sweden, Norway and Germany, and with a presence in Finland and Austria. As per 31 December 2016, Actic had approximately 211 000 members divided into 166 facilities in five countries with approximately 700 employees. During 2016, Actic’s total revenues amounted to approximately SEK 800 million. The company was formed in 1981 and its head office is situated in Solna.

Vinge’s team primarily consisted of Jonas Bergström, Jesper Schönbeck, David Andersson, Joel Wahlberg, Annika Nyberg Ekenberg and Christian Brelin. Linda Sengul, Johanna Wiberg and Marith Welin Berger provided advice regarding due diligence. Louise Brorsson Salomon, Helena Håkansson and Adam Sandberg provided advice relating to financing issues.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025